2016 Volume 62 Issue 6 Pages 199-205
Fifty-three patients (36 males, 17 females) with maxillary sinus cancer were treated at Kyushu University Hospital during 2000-2013. They were classified by T classification as T2 (n=7), T3 (n=14), T4a (n=26), and T4b (n=6). The 3-year cause-specific survival rates were 71.3% for all patients. The 3-year cause-specific survival rates were 62.5% for patients treated with intra-arterial infusion of 5-FU via superficial temporal artery with concomitant radiotherapy between 2000 and 2003, 74.6% for patients with oral S1 or superselective intra-arterial infusion of CDDP and docetaxel with concomitant radiotherapy between 2004 and 2008, and 75.9% for patients with chemo-radiotherapy following surgical resection and reconstruction after 2009. Chemo-radiotherapy following surgical resection improved the cause-specific survival rates.
